Semaglutide, a drug approved for diabetes and obesity, may be safe for older adults with early Alzheimer's, according to findings published in Alzheimer's & Dementia: Translational Research & Clinical Interventions. Most side effects, including nausea and other stomach issues, were mild, suggesting potential for wider use.